Sentinel Trust’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91K Hold
37,259
0.01% 134
2026
Q1
$88K Hold
37,259
0.01% 134
2025
Q4
$193K Hold
37,259
0.02% 130
2025
Q3
$157K Hold
37,259
0.02% 126
2025
Q2
$136K Hold
37,259
0.01% 126
2025
Q1
$161K Hold
37,259
0.02% 130
2024
Q4
$119K Hold
37,259
0.01% 128
2024
Q3
$107K Sell
37,259
-111,776
-75% -$313K 0.01% 138
2024
Q2
$417K Hold
149,035
0.05% 103
2024
Q1
$423K Hold
149,035
0.05% 105
2023
Q4
$610K Sell
149,035
-2
-0% -$6 0.08% 92
2023
Q3
$474K Hold
149,037
0.07% 100
2023
Q2
$495K Hold
149,037
0.07% 103
2023
Q1
$317K Hold
149,037
0.05% 113
2022
Q4
$401K Hold
149,037
0.06% 85
2022
Q3
$483K Hold
149,037
0.08% 77
2022
Q2
$727K Hold
149,037
0.11% 75
2022
Q1
$1.14M Buy
+149,037
New +$1.15M 0.14% 67

Other funds holding ORGO

Sentinel Trust's ORGO Position: Q2 2026 in Review

Sentinel Trust held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 37,259 shares worth $91K. The position accounts for 0.01% of the portfolio, ranked #134.

Sentinel Trust first reported a position in ORGO in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.14M in Q1 2022. 10 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Sentinel Trust held 37,259 shares of Organogenesis Holdings worth $91K as of Q2 2026.
  • Sentinel Trust left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up 0.01% of Sentinel Trust's portfolio in Q2 2026, its #134 holding.
  • Sentinel Trust first reported a position in Organogenesis Holdings in Q1 2022 and has held it in 18 quarters since.
  • Sentinel Trust's Organogenesis Holdings position peaked at $1.14M in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.